PIK3CA and cancer: PIK3CA, a member of the phosphatidylinositol 3’-kinase (PI3K) family, is ranked as the second most commonly mutated oncogene, detected in more than 10% of patients with eight types of cancer (Arafeh and Samuels, 2019).